beta-Galactosidase-1

beta-Galactosidase-1

beta-Galactosidase-1 Molekülinformation

Molecule Name
Beta-galactosidase
Molekülalias
EBP, ELNR1, MPS4B
Drug Development Progress
Anzahl der klinischen Arzneimittel2
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
EC:3.2.1.23,Elastin Binding Protein,GLB1,Elastin receptor 1,Galactosidase Beta 1,Elastin Receptor 1, 67kDa,Acid Beta-Galactosidase,Lactase,ELNR1,Elastin Receptor 1 (67kD),Galactosidase, Beta 1,Beta-Galactosidase,EC 3.2.1.23,MPS4B,EBP

beta-Galactosidase-1 Produktliste

Species
  • Human(1)
Tag
  • His Tag(1)
Host
  • HEK293(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
beta-Galactosidase-1
Human beta-Galactosidase-1 Protein, His Tag (active enzyme)
Human
HEK293
SDS-PAGE
Enzyme

$360.00

100ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Bomtabegagene bavoparvovecAAV9-GLB1; AXO-AAV-GM1Phase 2 ClinicalUniversity Of Massachusetts Medical School
Gangliosidoses
Details
GaxilosePhase 1 Clinical
Lactose Intolerance
Details
Customer Reviews